/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Cardiovascular and non-cardiovascular adverse events in patients with hematologic malignacies treated with BTK inhibitors: a real-world analysis
Event: ESC Congress 2024
Topic: Cardio-Oncology
Session: Challenges when caring for cancer patients with heart disease
Ten-year outcomes in patients with hypertension and primary hyperaldosteronism undergoing surgical adrenalectomy versus medical therapy: data from the multinational collaborative network TriNetX
Event: ESC Congress 2024
Topic: Secondary Hypertension
Session: Secondary and resistant hypertension
SGLT2 inhibitors in patients with amyloidosis and heart failure: a worldwide retrospective cohort study
Event: ESC Congress 2024
Topic: Cardio-Oncology
Session: Daily cardiac problems in cancer patients
Real-world analysis of transcatheter aortic valve replacement in patients with prostate cancer and severe aortic stenosis
Event: ESC Congress 2024
Topic: Cardio-Oncology
Session: Cardiovascular complications in cardio-oncology: risk assessment
Coronary angioplasty or medical treatment in patients with aortic stenosis and coronary artery disease undergoing transcatheter aortic valve implantation: a real world analysis
Event: ESC Congress 2022
Topic: Aortic Valve Intervention
Session: Transcatheter aortic valve implantation: the intangibles
Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib or nilotinib: data from a large multinational collaborative network
Event: ESC Congress 2022
Topic: Cardio-Oncology
Session: Cardio-oncology 3
Long-term survival analysis of patients with heart failure of different etiologies in a brazilian cohort of outpatients - a bayesian approach
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure – epidemiology, prognosis, outcome
